Publication | Closed Access

Treatment of hepatitis B virus-infected cells with α-glucosidase inhibitors results in production of virions with altered molecular composition and infectivity

HepatologyViral HepatitisMedicinePathogenesisImmunologyHepatitis BHepatitisVirologyAntiviral Drug DevelopmentAntiviral TherapyAntiviral DrugAltered Molecular CompositionPharmacologyAntiviral CompoundViral Immunityα-Glucosidase Inhibitors Results